Skip to main content
. 2021 May 24;34(1):171–179. doi: 10.1111/den.14010

Figure 3.

Figure 3

Treatment differences between bowel preparation with elobixibat and 1‐L PEG‐Asc versus with sodium picosulfate and 1‐L PEG‐Asc. The treatment difference in the excellent or good preparation status (BBPS score 6 or higher) was −4.0% (95% CI −9.3 to 1.5) in the per‐protocol analysis and −4.8% (95% CI −10.0 to 0.7) in the intention‐to‐treat analysis, falling within the 15% non‐inferiority margin. PEG‐Asc, polyethylene glycol formulation containing ascorbic acid.